Business Description
Benitec Biopharma Inc
NAICS : 325412
SIC : 2834
ISIN : US0820533075
Share Class Description:
BNTC: Ordinary SharesDescription
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 321.52 | |||||
| Equity-to-Asset | 0.93 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Piotroski F-Score | 5/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -67.8 | |||||
| 3-Year EBITDA Growth Rate | 53.2 | |||||
| 3-Year EPS without NRI Growth Rate | 53.4 | |||||
| 3-Year FCF Growth Rate | 53.2 | |||||
| 3-Year Book Growth Rate | -90.8 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.82 | |||||
| 9-Day RSI | 47.21 | |||||
| 14-Day RSI | 48.03 | |||||
| 6-1 Month Momentum % | 43.44 | |||||
| 12-1 Month Momentum % | 253.92 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 15.01 | |||||
| Quick Ratio | 15.01 | |||||
| Cash Ratio | 14.9 | |||||
| Days Payable | 526768 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -193.4 | |||||
| Shareholder Yield % | -27.48 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -25882.67 | |||||
| ROE % | -64.89 | |||||
| ROA % | -56.55 | |||||
| ROIC % | -1690.07 | |||||
| ROC (Joel Greenblatt) % | -4796.61 | |||||
| ROCE % | -69.27 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 186.85 | |||||
| PB Ratio | 2.81 | |||||
| Price-to-Tangible-Book | 2.81 | |||||
| EV-to-EBIT | -7.46 | |||||
| EV-to-EBITDA | -7.58 | |||||
| EV-to-Forward-EBITDA | -0.02 | |||||
| EV-to-Revenue | 2221.65 | |||||
| EV-to-FCF | -8.58 | |||||
| Price-to-Net-Current-Asset-Value | 2.83 | |||||
| Price-to-Net-Cash | 2.86 | |||||
| Earnings Yield (Greenblatt) % | -13.4 | |||||
| FCF Yield % | -8.29 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:BNTC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Benitec Biopharma Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.075 | ||
| EPS (TTM) ($) | -5.289 | ||
| Beta | 0.33 | ||
| Volatility % | 94.97 | ||
| 14-Day RSI | 48.03 | ||
| 14-Day ATR ($) | 0.646639 | ||
| 20-Day SMA ($) | 10.3815 | ||
| 12-1 Month Momentum % | 253.92 | ||
| 52-Week Range ($) | 2.69 - 12.89 | ||
| Shares Outstanding (Mil) | 23.22 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Benitec Biopharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Benitec Biopharma Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Benitec Biopharma Inc Frequently Asked Questions
What is Benitec Biopharma Inc(BNTC)'s stock price today?
The current price of BNTC is $10.09. The 52 week high of BNTC is $12.89 and 52 week low is $2.69.
When is next earnings date of Benitec Biopharma Inc(BNTC)?
The next earnings date of Benitec Biopharma Inc(BNTC) is 2025-02-13 Est..
Does Benitec Biopharma Inc(BNTC) pay dividends? If so, how much?
Benitec Biopharma Inc(BNTC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers